Lista de obras -

Asthma exacerbations on benralizumab are largely non-eosinophilic

artículo científico publicado en 2020

Direct and indirect bronchoprovocation tests in dose-response studies of inhaled corticosteroids: Past, present and future directions

artículo científico publicado en 2020

Dupilumab, Severe Asthma Airway Responses, and SARS-CoV2 Serology

artículo científico publicado en 2020

EAACI Biologicals Guidelines - Recommendations for severe asthma

scientific article published on 02 June 2020

Effect of sex on group 2 innate lymphoid cells in the airways of mild and severe asthmatics

scientific article published on 26 February 2019

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma

artículo científico publicado en 2020

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

artículo científico publicado en 2020

Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

artículo científico publicado en 2020

Loss of bronchoprotection to Salbutamol during sputum induction with hypertonic saline: implications for asthma therapy.

artículo científico publicado en 2018

Mechanisms and therapeutic strategies for non-T2 asthma

scientific article published on 14 August 2019

Monitoring eosinophils to guide therapy with Biologics in Asthma: does the compartment matter?

scientific article published on 10 December 2020

Much ado about Biologicals: Highlights of the Master Class on Biologicals, Prague, 2018

article published in 2019

Omalizumab in patients with severe asthma and persistent sputum eosinophilia

artículo científico publicado en 2019

Predictors of response to anti-IL-5 biologics

artículo científico publicado en 2020

Rapid quantification of sputum eosinophil peroxidase on a lateral flow test strip

scientific article published on 15 January 2019

Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.

artículo científico publicado en 2016

Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

scientific article published on 31 May 2019

Sputum and serum immunoglobulins in adult asthmatics with recurrent respiratory tract infections

artículo científico publicado en 2020

Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations.

artículo científico publicado en 2017

Lista de obras de

Asthma exacerbations on benralizumab are largely non-eosinophilic

Direct and indirect bronchoprovocation tests in dose-response studies of inhaled corticosteroids: Past, present and future directions

Dupilumab, Severe Asthma Airway Responses, and SARS-CoV2 Serology

EAACI Biologicals Guidelines - Recommendations for severe asthma

Effect of sex on group 2 innate lymphoid cells in the airways of mild and severe asthmatics

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma

Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma

Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma

Loss of bronchoprotection to Salbutamol during sputum induction with hypertonic saline: implications for asthma therapy.

Mechanisms and therapeutic strategies for non-T2 asthma

Monitoring eosinophils to guide therapy with Biologics in Asthma: does the compartment matter?

Much ado about Biologicals: Highlights of the Master Class on Biologicals, Prague, 2018

Omalizumab in patients with severe asthma and persistent sputum eosinophilia

Predictors of response to anti-IL-5 biologics

Rapid quantification of sputum eosinophil peroxidase on a lateral flow test strip

Revisiting Type 2-high and Type 2-low airway inflammation in asthma: current knowledge and therapeutic implications.

Severe asthma: Entering an era of new concepts and emerging therapies: Highlights of the 4th international severe asthma forum, Madrid, 2018

Sputum and serum immunoglobulins in adult asthmatics with recurrent respiratory tract infections

Sputum cell counts to manage prednisone-dependent asthma: effects on FEV1 and eosinophilic exacerbations.